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Mutagenesis screenWe identiﬁed three zebraﬁsh mutants with defects in biliary development. One of these mutants, pekin (pn),
also demonstrated generalized hypopigmentation and other defects, including disruption of retinal cell
layers, lack of zymogen granules in the pancreas, and dilated Golgi in intestinal epithelial cells. Bile duct
cells in pn demonstrated an accumulation of electron dense bodies. We determined that the causative defect
in pn was a splice site mutation in the atp6ap2 gene that leads to an inframe stop codon. atp6ap2 encodes a
subunit of the vacuolar H+-ATPase (V-H+-ATPase), which modulates pH in intracellular compartments. The
Atp6ap2 subunit has also been shown to function as an intracellular renin receptor that stimulates ﬁbrogen-
esis. Here we show that mutants and morphants involving other V-H+-ATPase subunits also demonstrated
developmental biliary defects, but did not demonstrate the inhibition of ﬁbrogenic genes observed in pn.
The defects in pn are reminiscent of those we and others have observed in class C VPS (vacuolar protein sort-
ing) family mutants and morphants, and we report here that knockdown of atp6ap2 and vps33b had an ad-
ditive negative effect on biliary development. Our ﬁndings suggest that pathways which are important in
modulating intracompartmental pH lead to defects in digestive organ development, and support previous
studies demonstrating the importance of intracellular sorting pathways in biliary development.
© 2012 Elsevier Inc. All rights reserved.Introduction
Understanding biliary development is vital to determining the
pathogenesis of hepatobiliary diseases that affect infants and new-
borns. Infantile biliary diseases result in cholestasis, or poor bile
ﬂow, which may lead to cirrhosis and eventual need for liver trans-
plantation. While only a minority of these conditions have a clear ge-
netic etiology, elucidation of the important genes, proteins, and
pathways involved in biliary development will lead to greater under-
standing of the disease processes and may lead to novel treatments.
We use the zebraﬁsh to model hepatobiliary development and
disease. There is generally a strong conservation in terms of the over-
all developmental process and in the importance of speciﬁc genetic
pathways. In mammals, bipotential hepatoblasts differentiate into he-
patocytes and bile duct cells, which form the intrahepatic bile ducts
along the developing portal veins, resulting in an arborizing network
that drains the liver (Lemaigre and Zaret, 2004). The process of biliary
development in mammals continues after birth. In zebraﬁsh,gy, Hepatology and Nutrition,
e, USA. Tel.: +1 267 426 7223.
tthews).
rights reserved.intrahepatic bile ducts lengthen and form connections, leading to a
lattice of ducts that drains the liver by around 5 dpf (days post fertil-
ization) (Lorent et al., 2004; Matthews et al., 2004), although the
ducts continue to grow and remodel after that time. Mediators of
intrahepatic bile duct formation in mammals, such as Onecut family
members (Clotman et al., 2002, 2005), the homeodomain transcrip-
tion factor Hnf1b (Cofﬁnier et al., 2002), and Jagged and Notch
(Kodama et al., 2004; Lozier et al., 2008), have generally conserved
function in zebraﬁsh biliary development (Lorent et al., 2004;
Matthews et al., 2004, 2008).
Mutagenesis screens in zebraﬁsh allow unbiased discovery of
genes important in developmental processes and disease pathogene-
sis. Numerous investigators have utilized mutagenesis screens to un-
cover genes involved in gut development (Pack et al., 1996), the effect
of maternally expressed genes on early development (Dosch et al.,
2004; Wagner et al., 2004), pigment formation (Pickart et al., 2004),
and multiple other developmental processes. The ﬂuorescent lipid re-
porter PED-6 has been utilized in a previous mutagenesis screen to
uncover fat-free (ffr), which demonstrates abnormal lipid processing
and defective intrahepatic biliary development (Ho et al., 2006).
PED-6 is a quenched phospholipid that is activated by phospholipase
A2, absorbed by the enterohepatic circulation, processed by the liver
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the extrahepatic biliary tree and will accumulate in the gallbladder
(Farber et al., 2001). In this study, we used PED-6 to screen for defects
in intrahepatic biliary development.
Here we report the identiﬁcation of three mutants with defects in
bile duct development. These mutants — pekin (pn), rouen (rou), and
cayuga (cay) — are phenotypically distinct. We report that pn is
caused by a mutation in atp6ap2, which encodes an accessory protein
to the vacuolar (V)-H+-ATPase. The V-H+-ATPase is a multisubunit
complex that is critical in lowering pH in lysosomes, endosomes and
synaptic vesicles (Forgac, 2007). It also acts at the plasma membrane,
lowering extracellular pH within the renal distal tubule (Saroussi and
Nelson, 2009). V-H+-ATPase activity and vesicular acidiﬁcation are
required for normal intracellular vesicular sorting (Mellman et al.,
1986; Sun-Wada et al., 2004). Other roles for intravesicular acidiﬁca-
tion include release and intracellular processing of endocytosed li-
gands, as well as mediating or preventing viral invasion of cells
(Toei et al., 2010). Others have reported zebraﬁsh mutants involving
V-H+-ATPase subunits, which all demonstrate hypopigmentation and
share defects in eye development (Amsterdam et al., 2004; Gross et
al., 2005; Wang et al., 2008).
Interestingly, in mammals, Atp6ap2 also acts as an intracellular
renin receptor that activates ERK1 and ERK2 (Nguyen et al., 2002)
and also directly interacts with the transcription factor promyelocytic
leukemia zinc ﬁnger (PLZF, Zbtb16) (Schefe et al., 2006). Prior to the
discovery of a distinct renin receptor, renin was known as a protease
that activates angiotensin, which upon further modiﬁcation acts to
increase blood pressure by vasoconstriction and by stimulating the
release of aldosterone and anti-diuretic hormone. The physiologic ac-
tions of the renin receptor (Atp6ap2) overlap some of the effects of
renin itself, including increasing blood pressure (Burckle et al.,
2006) and activating ﬁbrosis (Jan Danser et al., 2007).
Our results demonstrate that the V-H+-ATPase mutant pn
exhibits developmental biliary defects, most likely via effects on
the generation of intracellular pH and vesicular trafﬁcking, and
not via effects on renin receptor activity. Knockdown or mutation
of genes in intracellular trafﬁcking pathways has been shown
previously to lead to abnormal biliary development in zebraﬁsh
(Matthews et al., 2005; Sadler et al., 2005; Schonthaler et al.,
2008), and patients with a homozygous mutation in the intracellu-
lar trafﬁcking gene VPS33B develop severe cholestasis (Gissen et al.,
2004). These ﬁndings, along with those presented here, stress the
importance of intracellular trafﬁcking pathways in biliary develop-
ment and disease pathogenesis.
Materials and methods
Mutagenesis screen for biliary defects
A chemical mutagenesis screen using ethylnitrosourea (ENU) was
performed essentially as described previously (Dosch et al., 2004;
Wagner et al., 2004), screening the equivalent of 600 genomes. We
used PED-6 to screen for families in which 1/4 of the F3 members
demonstrated diminished gallbladder uptake, similar to the previous
(Farber et al., 2001; Ho et al., 2006). PED-6 is a ﬂuorescent lipid com-
pound that is activated in the intestine and absorbed via the entero-
hepatic circulation into the liver, where it is processed in the
hepatocyte and excreted into the bile, accumulating in the gallbladder
(Farber et al., 2001). Lack of gallbladder accumulation suggests possi-
ble abnormalities in intrahepatic biliary development. All ﬁsh were
cared for in the zebraﬁsh facility at the University of Pennsylvania
or The Children's Hospital of Philadelphia Research Institute, in accor-
dance with Institutional Animal Care and Use Committee guidelines
of both institutions.
Genetic identiﬁcation of pn was performed on F2 progeny, to take
advantage of the generation of mutant carriers in AB/Tü strainhybrids. A large panel of standard z-markers was used to establish
linkage on chromosome 22, and ﬁner mapping was performed using
primers listed in Supplemental Table 1. Candidate genes were identi-
ﬁed based on available sequence data (www.sanger.ac.uk) and se-
quenced using primers designed on the available in silico sequence.
Screening for carrier heterozygotes was performed using TaqMan
primers containing the single nucleotide polymorphism (SNP) consti-
tuting the mutation (Table S1). The altered transcript in the mutant
was conﬁrmed using standard and quantitative PCRs, with primers
shown in Table S1.
Additional mutant lines were obtained from the zebraﬁsh
international resource center (ZIRC). These lines were originally
uncovered in an insertional mutagenesis screen in the Hopkins
laboratory (Amsterdam et al., 1999). The lines included hi3681
(atp6ap2), hi112 (atp6ap1), and hi2188b (atp6v0d1). In addition,
we used morpholinos directed against atp6v1a (Supplemental
Table 2) to establish additional models of V-H+-ATPase subunit
mutants.
In situ hybridization
In situ hybridizations were performed as described previously
(Cui et al., 2011a), except that 0.25% acetic anhydride was added
after proteinase K ﬁxation to reduce background (Westerﬁeld,
2000). Primers for synthesis of the foxa3, atp6ap2 and dct probes are
noted in Table S2. As a control, larvae with no riboprobe added
were processed identically to the samples with riboprobes.
Tissue histology and immunostaining
For experiments involving conventional stainings such as hema-
toxylin and eosin, 5 dpf larvae were ﬁxed in 4% paraformaldehyde,
embedded in parafﬁn, and sectioned. Slides were treated as per stan-
dard protocol and then stained with hematoxylin and eosin. Staining
for Atp6ap2 was performed on unstained sections from wild-type
5 dpf larvae in accordance with standard techniques, using an anti-
body against the renin receptor (H-85; sc-67390; Santa Cruz Biotech-
nology). As a negative control, sections were treated using the same
protocol but without primary antibody.
Whole-mount cytokeratin and 2F11 staining were performed as
previously described, after ﬁxation in methanol/DMSO or paraformal-
dehyde (Matthews et al., 2008). Duct quantiﬁcation was performed
identically to the previous one (Cui et al., 2011a).
Electron microscopy
Samples for electron microscopy were obtained at 5 dpf. Larvae
were ﬁxed in buffered glutaraldehyde and prepared as previously de-
scribed (Matthews et al., 2005). Sections were examined at the Penn
Bio-Imaging Core, as previously done.
Non-quantitative PCR and quantitative real-time PCR
Samples for examination of atp6ap2 expression were obtained by
dissecting the liver out of 5 dpf larvae. RNA was isolated from the
liver and from separate whole wild-type larva in pooled batches of
5 larvae, reverse transcribed and PCR was performed with primers
shown in Supplemental Table 3.
Samples for quantitative real-time PCR were obtained at 5 dpf.
RNA was isolated from the whole larvae and was reverse transcribed
as per standard protocols, and QPCR was performed generally in ac-
cordance with standard protocols, using a StepOne Plus from ABI.
Primers are depicted in Supplemental Table 3. Normalization was
performed using hprt. Graphs depicted are representative experi-
ments comparing 4 individual biological replicates per condition, in
quadruplicate.
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Morpholinos to vps33b, atp6ap2, atp6v1a and ren were obtained
from Gene-Tools (Philomath, OR). Sequences of the atp6ap2,
atp6v1a and ren MOs are depicted in Table S2. Morpholinos were
injected at the one-cell stage, similar to previous, and titrated to ef-
fect. We have previously demonstrated functionality and speciﬁcity
of the vps33b MOs (Matthews et al., 2005). Quantitative PCR docu-
mentation of the effect of atp6v1a is shown in Fig. S1.
Results
Screen for developmental biliary defects
We participated in a multi-investigator ENU mutagenesis screen,
similar to previous studies (Dosch et al., 2004; Wagner et al., 2004).
We screened F3 families for biliary defects using the ﬂuorescent
lipid reporter PED-6, which has previously been used as a screening
tool for developmental biliary defects in zebraﬁsh (Farber et al.,
2001; Ho et al., 2006). We identiﬁed several F3 families with distinct
abnormalities in gallbladder PED-6 accumulation, of which we pre-
sent the initial characterization of three. The general appearance of
and lack of gallbladder PED-6 in the mutants pekin (pn), rouen
(rou), and cayuga (cay) are depicted in Fig. 1. Of these mutants, pn
was also notable for generalized hypopigmentation, and rou demon-
strated cardiac edema. All three mutants demonstrated smaller eyes
and an underinﬂated swim bladder, and pn and rou demonstrated
underutilized yolk. The lack of gallbladder PED-6 in these mutants
suggested possible defects in biliary development.
Mutants with intrahepatic biliary defects
We examined pn, rou, and cay for defects in intrahepatic biliary
development using whole-mount cytokeratin immunostaining ofFig. 1. Novel mutants with abnormal PED-6 uptake. (A–D) Left lateral views of live 5 dpf wild
global hypopigmentation, underutilized yolk (y), absent swim bladder and some brain edem
normal intensity of the gallbladder in wt (E, white arrow), but absent gallbladders in the mliver from 5 dpf larvae, similar to previous studies (Ho et al., 2006;
Lorent et al., 2004; Matthews et al., 2004, 2005, 2008). All three mu-
tants demonstrated distinct and severe defects of intrahepatic biliary
anatomy at 5 dpf when compared to wild-type (Fig. 2). The staining
pattern in pn demonstrated a similar number of ducts as seen in
wild-type, but shorter and wider, with a modest decrease in the inter-
connecting ducts and terminal ductules that appear later in develop-
ment (Fig. 2 and Table 1). In contrast, rou livers appeared even more
abnormal, with signiﬁcantly fewer ducts almost devoid of intercon-
necting ducts and terminal ductules. The ductal network of cay
appeared to have fewer ducts than wild-type but the ducts were of
a similar length, although cay ducts also demonstrated decreased
numbers of interconnecting ducts and terminal ductules. These pat-
terns are schematized in Fig. 2 and quantiﬁed in Table 1. We also ex-
amined our mutants using the bile duct cell marker 2F11 (Crosnier et
al., 2005). Using this marker, pn appeared to have smaller bile duct
cell bodies, rou was devoid of bile duct cells, and cay was difﬁcult to
distinguish from wild-type (Fig. 2).
Ultrastructural examination of the mutants demonstrated distinct
ﬁndings as well. As depicted in Fig. 2, bile duct cells in pn demonstrat-
ed accumulation of electron dense bodies at the periphery of the cell,
with an accumulation of vesicles or dilation of the smooth endoplas-
mic reticulum as well. As depicted in the inset (Fig. 2N′), the electron
dense bodies appeared striped, resembling “zebra bodies”, which
have been described in patients with lysosomal storage diseases
(Aleu et al., 1965). Along with the dilated vesicular structures, this
suggested that there might be a defect in protein targeting or degra-
dation in pn. We were unable to ﬁnd bile duct cells in rou by electron
microscopy, consistent with the cytokeratin and 2F11 immunostain-
ings, and areas in the liver that normally contain bile duct cells
were occupied by large cells, probably macrophages, with multiple
structures within (Fig. 2O). The continued presence of apparent cyto-
keratin staining at 5 dpf without evidence for bile duct cells at that
stage could be due to remnants of ductal structures that appeared-type (A, wt), pekin (B, pn), rouen (C, rou), and cayuga (D, cay) larvae. pn demonstrates
a. (E–H) Right lateral views of the same 5 dpf larvae after PED-6 uptake, demonstrating
utants (F–H, white arrows).
Fig. 2. Intrahepatic biliary defects in novel mutants. (A–D) Confocal projections of whole-mount cytokeratin immunostaining of livers from 5 dpf wild-type (A, wt), pekin (B, pn),
rouen (C, rou), and cayuga (D, cay) larvae, schematized in (E–H). The typical wt pattern is depicted in (A) and schematized in (E), demonstrating a complex latticework. In contrast,
the staining pattern of pn (B, F) demonstrates shorter ducts with fewer interconnections. The staining pattern of rou (C, G) demonstrates an absence of recognizable ducts. The
cytokeratin staining pattern of cay (D, H) demonstrates short non-interconnected ducts, with some terminal ductules. (I–L) Confocal projections of whole-mount 2F11 immunos-
taining of livers from 5 dpf wt (I), pn (J), rou (K), and cay (L) larvae. 2F11 stains bile duct cell bodies (white arrowheads) and proximal ducts, as demonstrated in wt (I). The 2F11
pattern of pn demonstrates fewer ducts, with smaller bile duct cells. There are no apparent bile duct cells in 2F11 stainings of rou (K), and cay (L) is similar to wt. (M–P) Electron
micrographs of livers from 5 dpf wt (M), pn (N), rou (O), and cay (O) larvae. In (M), the wt hepatocyte (hep) and bile duct cell (bdc) are depicted. In contrast, the bdc in pn (N)
contains an accumulation of electron dense material (black arrow) at the periphery of the cell. The inset (N′) demonstrates that these bodies have a striped appearance, and the
dilated vesicles (black arrowhead) are also apparent. The cell in rou (O) is most likely a macrophage (mac), in the space normally occupied by bile duct cells. In contrast, the
bdc of cay (P) appears close to normal, but with nuclei that are modestly enlarged relative to the cytoplasm when compared to wt (M), and with an appearance more closely re-
sembling the hep nucleus. Scale bars in (M–P) 500 nm, N′ also 500 nm.
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duct cells. The ultrastructural defects of cay appeared subtle, as the
nuclei of the bile duct cells appeared mildly enlarged relative to theTable 1
Quantiﬁcation of duct characteristics of mutants and morphants. Shown are average numb
and angle. N=6 samples per condition for wt, pekin, rouen, and cayuga; N=3 for atp6ap1−
# total ducts # int. ducts # terminal du
wt 37.3±9.8 13.5±6.2 93.8±23.5
Pekin 49.2±20.6 1.2±1.2⁎⁎ 35.3±28.5⁎⁎
Rouen 13.3±2.0⁎⁎⁎ 1.3±1.0⁎⁎ 0.2±0.4⁎⁎⁎
Cayuga 17.2±6.5⁎⁎ 1.6±1.3⁎⁎ 9.6±7.7⁎⁎⁎
atp6ap1−/− 48.7±6.4 4.3±0.6⁎ 39.7±19.4⁎
atp6v0d1−/− 29.5±16.3 0.0±0.0⁎⁎ 6.0±5.7⁎⁎
atp6v1a MO 50.0±3.6 3.0±1.0⁎ 24.0±8.7⁎⁎
atp6ap2 MO 35.0±7.8 0.8±0.5⁎⁎ 32.3±8.3⁎⁎
⁎ p≤0.05.
⁎⁎ p≤0.005.
⁎⁎⁎ p≤0.0005.cytoplasm and the bile duct cells themselves appeared somewhat
more similar to the hepatocytes (Fig. 2P). These results demonstrate
that the intrahepatic biliary defects in pn, rou, and cay are distinct.er of total ducts, interconnecting ducts (IC), and terminal ductules, duct length, width,
/−, atp6v0d1−/−, atp6v1a MO and atp6ap2 MO.
ctules Length Width Angle
1.55±0.15 0.320±0.051 73±10
0.97±0.14⁎⁎⁎ 0.457±0.113⁎ 70±7
0.87±0.21⁎⁎⁎ 0.559±0.077⁎⁎⁎ 82±16
1.64±0.33 0.478±0.075⁎⁎ 86±10
1.07±0.30⁎ 0.356±0.038 76±13
0.72±0.12⁎⁎⁎ 0.325±0.025 76±25
0.97±0.19⁎⁎⁎ 0.351±0.048 79±14
1.01±0.09⁎⁎⁎ 0.434±0.048⁎ 79±7
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Genetic characterization of pn demonstrated a mutation in the in-
tron–exon boundary at the end of the 8th exon of the gene atp6ap2,
c.980+2 T−>G, resulting in a read-through and premature stop
codon (Fig. 3). No mutations were detected in the neighboring
genes depicted in Fig. 3. Semi-quantitative PCR of pn cDNA demon-
strated the presence of a larger band corresponding to the alternate
splice product (Fig. 3B), conﬁrmed by sequence analysis, which is
dramatically increased in pn (Fig. 3C). Successful non-
complementation using the atp6ap2 insertional mutant hi3681 con-
ﬁrmed that the causative gene of pn is atp6ap2. Of note, phenotypic
analysis of hi3681 was indistinguishable from pn (data not shown).
Injection of morpholino antisense oligonucleotides directed against
the atp6ap2 translational start site, splice acceptor site of exon 2, or
splice donor site of exon 8 led to diminished gallbladder uptake andFig. 3. Mapping and genetic characterization of pn. (A) Schematic of mapping around the p
recombinant marker in the bcor gene. A splice donor site mutation following exon 8 of atp6a
the wild-type (wt) and pn splice products, demonstrating the presence of the higher band
and pn atp6ap2 splice products, demonstrating a 10× reduction in the wt product in pn, and
ization of atp6ap2 at 5 dpf demonstrates liver (“li”) and intestinal (“int”) expression of atp6a
5 dpf larva without atp6ap2 riboprobe, with no speciﬁc staining. (E) Immunostaining of Atp
creas (“p”), and gallbladder (“gb”). The area within the white rectangle is shown in E′, demon
within the liver. (E″) Liver section from a 5 dpf larva processed similarly but without primary
(E″) are counterstained with DAPI to show nuclei. (F) PCR of atp6ap2 from 5 dpf whole larva
Quantitative PCR demonstrating a 5× decrease in pi3kr1 expression, a gene regulated by Aabnormal intrahepatic ducts similar to pn (data not shown). The
atp6ap2 gene was ubiquitously expressed at low levels throughout
the developing embryo and larva, including the developing liver at
3 dpf (data not shown and www.zﬁn.org). At 5 dpf, atp6ap2 was
expressed relatively faintly in the liver, as well as in mucus cells in
the skin, as determined by in situ hybridization and by PCR from
livers isolated from 5 dpf larvae (Fig. 3). Immunostaining demon-
strated punctate staining consistent with vesicular localization in
5 dpf digestive organs (Fig. 3). These ﬁndings demonstrate that the
causative gene of pn is a mutation in atp6ap2, thus suggesting that a
mutation in atp6ap2 leads to the biliary phenotype of pn. Interesting-
ly, similar low levels of expression were noted of cog8, the causative
gene of ffr (Ho et al., 2006). Genetic analysis of rou and cay is ongoing.
The hypopigmentation found in other zebraﬁsh V-H+-ATPase mu-
tants (Amsterdam et al., 2004; Gross et al., 2005; Wang et al., 2008)
supports a role for Atp6ap2 in V-H+-ATPase activity. Decreasedn locus. A region of interest on chromosome 22 was identiﬁed as depicted, with a zero
p2was detected in pnmutants, which would result in the depicted sequence. (B) PCR of
(atp6ap2*), corresponding to the read-through product. (C) Quantitative PCR of the wt
a very large increase in the amount of the mutant transcript in pn. (D) In situ hybrid-
p2, shown in higher magniﬁcation in D′. Compare to (D″), which is a similarly processed
6ap2 in 5 dpf cross-sections demonstrates staining in liver (“li”), intestine (“int”), pan-
strating punctate staining (white arrowheads), consistent with a vesicular localization,
antibody, at the samemagniﬁcation as (E′), showing no punctate staining. (E), (E′) and
e (w) and from livers (li) isolated from 5 dpf larvae, showing expression of atp6ap2. (G)
tp6ap2 via PLZF.
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activity, affecting intracompartmental pH. As mentioned above, the
V-H+-ATPase has numerous effects and thus an inability to lower
intracompartmental pH could have effects on ligand processing,
intracellular sorting, degradation of proteins in the lysosomes, or
other effects. Atp6ap2 also acts as an intracellular renin receptor,
with downstream effects on ERK and the transcription factor PLZF.
Consistent with previous reports, pn larvae demonstrated decreased
expression of pik3r (Fig. 3), a downstream target of PLZF (Schefe
et al., 2006) that encodes the p85α subunit of phosphoinositol-3-
kinase. These ﬁndings suggest that at least some of the functions of
Atp6ap2, including effects on PLZF targets and skin hypopigmenta-
tion, are conserved in zebraﬁsh.
We have uncovered a mutation in a gene encoding a protein with
two roles: modulation of V-H+-ATPase activity and intracellular renin
receptor. Modulation of V-H+-ATPase activity will lead to a decreased
ability to acidify intracellular compartments, and thus could have an
effect on protein degradation or trafﬁcking consistent with the de-
fects noted in pn biliary cells by ultrastructure. We hypothesized
that the Atp6ap2 effects on V-H+-ATPase activity, and not the effects
mediated as the renin receptor, led to the biliary defects. We were
also interested in other defects in pn, to determine the effects of mu-
tation of atp6ap2 on other tissues.
Additional defects in pn
Genetic identiﬁcation of atp6ap2 as the causative gene in pn
allowed us to examine pn in greater depth. We examined pn larvae
at 4 dpf to determine the extent of the intrahepatic biliary defects at
that stage. Previous work has demonstrated that in the initial stages
of intrahepatic biliary development, scattered ducts lengthen andFig. 4. Additional defects in pn larvae. (A–D) Confocal projections of whole-mount cytokerat
onstrating abnormalities at this earlier stage. Ducts are short and demonstrate few if any con
stainings of cross-sections of 5 dpf wt (E) and pn (F) larvae, demonstrating that at this resol
the eye from a 5 dpf wt (G) and pn (H) larva. Note the ordered appearance of the cell layers
retinal pigmented epithelial (rpe) layers. In contrast, cells in these layers are disordered in pn
rpe is also poorly formed in pn. (I–L) Electron micrographs of pancreas (I–J) and enterocyte
ules (zg) in wt pancreas is absent in pn, although there are small structures that may repres
lated relative to the Golgi of wt (K). n, nucleus. Scale bars 500 nm.then become interconnected, with the terminal ductules, or anasta-
moses with hepatocyte canaliculi, appearing while these interconnec-
tions are being made (Lorent et al., 2004, 2010; Matthews et al.,
2004). Defects in intrahepatic biliary anatomy in pn were severe at
4 dpf, with shorter ducts and a lack of interconnecting ducts and ter-
minal ductules (Fig. 4), similar to the phenotype at 5 dpf. The pattern
of intrahepatic ducts in pn at 4 and 5 dpf suggested that the develop-
ment of intrahepatic bile ducts in pn is relatively speciﬁc, especially
when compared to the overall normal appearing liver at 5 dpf by he-
matoxylin and eosin stainings (Fig. 4E–F). This suggests that liver de-
fects in pn are defects in either bile duct formation or on the biliary
cells themselves, based on the abnormal appearance of these cells
by ultrastructure (Fig. 2M–N).
The ultrastructural appearance of bile duct cells in pn suggested
defects in protein trafﬁcking or impairment in protein degradation,
which is consistent with the previously described effects of inhibition
of the V-H+-ATPase. Hypopigmentation, as seen in pn, is a common
phenotype in other V-H+-ATPase mutants. We were unable to ﬁnd
melanocytes in 5 dpf pn larvae (data not shown), and there was de-
creased expression of the melanoblast marker dct at 5 dpf by qPCR, al-
though melanoblast expression of dct appeared normal at 24 hpf
(Supplemental Fig. 2), suggesting that melanocytes are forming prop-
erly but degrade. Because pn eyes also appeared hypopigmented, we
examined eye anatomy at 5 dpf. Cell layers within the eye were dis-
rupted in pn (Fig. 3G–H), with the most striking abnormalities in
the retinal cell layer and the retinal pigmented epithelium. These
ﬁndings are similar to previous descriptions of eye pigmentation mu-
tants caused by mutations in genes encoding subunits of the V-H+-
ATPase and vacuolar protein sorting (VPS) complexes (Navarro et
al., 2008), complexes important in intracellular protein trafﬁcking
and degradation.in immunostaining of livers from 4 dpf wild-type (A, wt) and pekin (B, pn) larvae, dem-
nections. These abnormalities are schematized in (C–D). (E–F) Hematoxylin and eosin
ution the liver of a pn larva appears normal. (G–H) Hematoxylin and eosin stainings of
in the wt eye, including the inner ganglionic (ig), outer ganglionic (og), retinal (r), and
, in particular in the retinal layer, which is difﬁcult to distinguish from the og layer. The
s (K–L) from wt (I, K) and pn (J, L). Note that the presence of numerous zymogen gran-
ent poorly formed zg (black arrow). The Golgi (g) in the pn enterocyte (L) appears di-
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those caused by defects in other trafﬁcking genes, such as ffr, in
which there is a mutation in the Golgi protein Ffr/Ang2 and there
are defects in both exocrine pancreas and in intestinal ultrastructure
(Ho et al., 2006). Examination of expression of the early digestive
organ marker foxa3 in atp6ap2 morphants at 36 hpf demonstrated
no abnormalities (Supplemental Fig. 3), suggesting that early gut de-
velopment is not affected by inhibition of atp6ap2. There were no zy-
mogen granules in the pancreas of 5 dpf pn larvae (Fig. 4I–J), and
close examination of pn enterocytes demonstrated dilated Golgi
(Fig. 4K–L). These ﬁndings were similar to defects found in ffr,
which also demonstrate abnormal bile duct morphology (Ho et al.,
2006). The biliary and pancreatic defects in pn are more severe
when compared to ffr, however, and ffr larvae are normally pigmen-
ted. Thus, pn phenotypes involving hypopigmentation of the skin
and eye, as well as digestive organ abnormalities also observed in
other trafﬁcking mutants strongly suggest that trafﬁcking defects
lead to the pn phenotype. Skin hypopigmentation, lack of zymogen
granules, and the presence of electron dense material in biliary cells
are distinct ﬁndings that we and others have not seen previously in
several mutants and morphants with biliary developmental defects
(Cui et al., 2011a, b; Lorent et al., 2004; Matthews et al., 2004, 2008,
2009, 2011; Sadler et al., 2005; Yee et al., 2005).
Biliary defects in other V-H+-ATPase subunit mutants
Atp6ap2 mediates the function of V-H+-ATPase, and also trans-
mits signals through ERK and through transcription factors such as
PLZF. To determine whether inhibition of V-H+-ATPase activity
leads to biliary defects, we examined other V-H+-ATPase mutants
for abnormalities in biliary development. The ability to transmit sig-
nals through ERK and PLZF appears to be unique to Atp6ap2 and its
role as the intracellular renin receptor. Thus, developmental biliary
defects in multiple V-H+-ATPase mutants would suggest that these
defects are due to abnormalities in vesicular acidiﬁcation.
In addition to pn, there are several zebraﬁsh lines in which there is
a mutation in a subunit of the V-H+-ATPase, including atp6v0d1,Fig. 5. Intrahepatic biliary defects in other V-H+-ATPase mutants. (A–D) Right lateral views
larva demonstrates normal gallbladder intensity (white arrow). (B) 5 dpf atp6v0d1−/−muta
vae all demonstrate a decrease or lack of gallbladder ﬂuorescence (white arrows). (E–H)
atp6v0d1−/−, atp6ap1−/−, and atp6v1a MO-injected larvae. The abnormal cytokeratin patt
focal areas of ectatic ducts.atp6ap1 and others. These mutants were uncovered as part of a
large insertional mutagenesis screen (Amsterdam et al., 1999). Gall-
bladder PED-6 uptake in atp6v0d1 and atp6ap1 mutants and in
atp6v1amorphants was diminished, similar to pn (Fig. 5). As depicted
in Fig. 5 and Table 1, cytokeratin immunostaining of whole-mount
liver from 5 dpf atp6v0d1−/−, atp6ap1−/−, and atp6v1amorphant lar-
vae demonstrated a decrease in the number and complexity of intra-
hepatic ducts, similar to pn. Of note, knockdown of ren (renin) led to
minor defects in biliary development difﬁcult to distinguish from
control and less signiﬁcant than defects in pn and other V-H+-ATPase
mutants and morphants (Supplemental Fig. 4). These results are con-
sistent with a role for V-H+-ATPase and have an importance in intra-
cellular vesicular acidiﬁcation in zebraﬁsh biliary development.
Examination of ﬁbrogenic gene expression changes in pn and other
V-H+-ATPase mutants
Asmentioned above, in addition to the effects on V-H+-ATPase ac-
tivity, Atp6ap2 mediates effects via ERK and PLZF after activation by
renin. The effects leading to hypopigmentation and biliary develop-
ment appear to be shared with at least three other V-H+-ATPase sub-
unit genes (Fig. 5). Downstream effects of renin via the renin receptor
include stimulatory effects on ﬁbrogenesis, and thus ﬁbrogenic gene
expression changes might be mediated via PLZF or ERK. We examined
ﬁbrogenic gene expression changes in pn as a marker of Atp6ap2 ac-
tivity independent of V-H+-ATPase effects. As depicted in Fig. 6, there
was a decrease in early markers of ﬁbrosis such as hsp47 (Masuda et
al., 1994), vime, and col1a1 in pn, suggesting that the ﬁbrogenesis
pathway is inhibited in pn. Similar results were obtained in hi3681
mutants and in atp6ap2 morphants (data not shown). In contrast,
there was no change in expression of these genes in atp6v0d1 or
atp6ap1 mutants, or in atp6v1a morphants, while there was a signiﬁ-
cant decrease in expression in ren morphants (Supplemental Fig. 5).
These ﬁndings, along with demonstration that ren knockdown has
no effect on biliary development (Fig. S4), suggest that the effects of
Atp6ap2 on biliary development and involving changes in ﬁbrogenic
gene expression are separable, and support a more important roleof 5 dpf larvae after administration of the ﬂuorescent lipid reporter PED-6. (A) Control
nt, (C) 5 dpf atp6ap1−/−mutant, and (D) 5 dpf atp6v1amorpholino (MO)-injected lar-
Confocal projections of cytokeratin immunostaining of 5 dpf liver from control (E),
ern in (F–H) has similarities to the pattern noted in pn, with fewer ducts overall and
Fig. 6. Changes in ﬁbrogenic gene expression in pn. Quantitative real-time PCR on pn for hsp47 (A), vimentin (vime) (B), and collagen I(α)I (col1a1) (C). There is a signiﬁcant de-
crease (pb0.03, pb0.05, pb0.01) for all the three genes. QPCR results for the other V-H+-ATPase gene mutants and morphants show minimal changes and are depicted in Supple-
mental Fig. 5.
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Thus, intracellular compartmental pH regulation appears more im-
portant in mediating biliary development, as opposed to the renin re-
ceptor function of Atp6ap2.
Inhibition of atp6ap2 and vps33b affects biliary development
We and others have demonstrated the importance of genes in
intracellular trafﬁcking and sorting pathways in zebraﬁsh intrahe-
patic biliary development, as mutation or knockdown of vps33b,
vps18, and vps39 leads to abnormal biliary development
(Matthews et al., 2005; Sadler et al., 2005; Schonthaler et al.,
2008). These genes encode proteins important in the docking of
membrane vesicles, in particular in mediating the progression of
late endosomes to lysosomes. Given the importance of low pH
in lysosome function, we hypothesized that atp6ap2 and otherFig. 7. Additive effect of vps33b and atp6ap2 inhibition. (A) Gallbladder PED-6 uptake in 5 d
larvae injected with a low dose of vps33b MO, and larvae injected with a combination of the
ferent between either of the MOs alone compared to control, but the number of larvae with
compared to control (pb0.01) and to either of the MOs alone (pb0.01 for atp6ap2, pb0.05 fo
corresponding to the conditions depicted in the graph in (B), showing control (B, cont), low-
low dose (E). Note that (C) and (D) are similar to (B), while (E) more closely resembles the p
all PED-6 classiﬁcations.V-H+-ATPase genes might be mediating a similar effect on intrahe-
patic biliary development. Thus, we performed morpholino-
mediated knockdown experiments using morpholinos against
vps33b and atp6ap2. Similar to previous experiments, we injected
morpholinos at concentrations that alone produced only a mild ef-
fect. As demonstrated in Fig. 7, when combined, injection of the
morpholinos at the lower amounts led to abnormal intrahepatic bil-
iary development, suggesting that the two genes are functioning in
the same pathway at some level. Fig. 7 also demonstrates that the
effect on development of either morpholino alone at lower concen-
trations is in fact mild, while together they exert an effect similar to
that seen in pn. This suggests that VPS-mediated effects and V-H+-
ATPase-mediated effects converge, possibly on the same intracellu-
lar compartment or both affecting transport of a critical mediator,
and that inhibition of this function leads to abnormal intrahepatic
biliary development.pf control larvae (cont), larvae injected with a low dose of atp6ap2 morpholino (MO),
low dose MOs. The number of larvae with faint gallbladders was not signiﬁcantly dif-
faint gallbladders after injection of the combination of MOs was signiﬁcantly increased
r vps33b). (B–E) Confocal projections of cytokeratin immunostaining from 5 dpf larvae
dose atp6ap2MO (C), low-dose vps33bMO (D), and the combination of the two MOs in
n defects shown above. Samples depicted in B–E are representative of pooled samples of
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Here we have presented three novel zebraﬁsh mutants with de-
velopmental biliary defects. One of these mutants, pn, is caused by
mutation of the atp6ap2 gene, which encodes a protein that acts as
part of the V-H+-ATPase complex. This complex has been shown to
modulate pH in intracellular vesicles, and the Atp6ap2 subunit has
been shown to have an additional role as an intracellular renin re-
ceptor. Several zebraﬁsh mutants and morphants of genes shown to
be important in intracellular trafﬁcking are associated with intrahe-
patic biliary defects, and we demonstrate that knockdown of
atp6ap2 is additive with knockdown of vps33b. These results sug-
gest that in zebraﬁsh, inhibition of pathways important in intracel-
lular trafﬁcking and in protein degradation negatively affects
intrahepatic biliary development.
The three mutants reported here that were uncovered by screen-
ing with the lipid reporter PED-6 support this as a useful screening
method. Previously, ffr was uncovered by PED-6, and additional mu-
tants from this screen will be reported elsewhere. Each of the mutants
reported here appears distinct, with different overall appearance and
different cytokeratin patterns and ultrastructural appearance. Thus,
further mutants could be uncovered by this method, as we do not ap-
pear to have reached saturation. Certainly our method of screening
for biliary defects at 5 dpf will not uncover mutants in genes affecting
vital early processes, as those mutants are not likely to be viable at
5 dpf. Thus, our screen selects for genes that do not have an additional
function that is vital in the early embryo. Interestingly, to date this
has resulted in the uncovering of two genes shown to have roles asso-
ciated with intracellular trafﬁcking, in ffr and pn.
Intracellular trafﬁcking pathways and biliary development
This report represents the ﬁfth example of a zebraﬁsh mutant or
morphant in which presumed defects in intracellular trafﬁcking,
broadly deﬁned, are associated with developmental biliary defects.
Others include ffr, vps18 and vps39 mutants and vps33b morphants.
These models share other defects, including intestinal and pancreatic
abnormalities and hypopigmentation (although not all of these
models demonstrate all of these phenotypes), which are not seen in
other zebraﬁsh biliary mutants. The gene affected in ffr encodes a
COG family protein; the COG complex has been shown to be impor-
tant in mediating vesicular transport to, from and within the Golgi
in yeast and in mammalian cells (Oka and Krieger, 2005). VPS18,
VPS39 and VPS33B are vacuolar sorting proteins that mediate trafﬁck-
ing between late endosomes and lysosomes in multiple model sys-
tems ranging from yeast and plants to mammals (Nickerson et al.,
2009). As stated above, the V-H+-ATPase complex has been shown
to be important in acidifying intracellular vesicles, including late
endosomes and lysosomes, in multiple model systems including
yeast (Forgac, 2000), Drosophila (Yan et al., 2009), ﬁsh (Kern et al.,
2002) and mammalian (Nakamura et al., 1997) cell culture, and
others. Zebraﬁsh models affecting these complexes likely disrupt in-
tracellular trafﬁcking pathways, leading to abnormal protein target-
ing and/or degradation.
Several liver diseases result from mistargeting of proteins, al-
though the primary defect in these diseases is not a defect in the
trafﬁcking pathway. Alpha-1-antitrypsin deﬁciency results in the
accumulation of alpha-1-antitrypsin in the endoplasmic reticulum,
leading to liver disease (Carlton et al., 2004). Patients with cystic
ﬁbrosis may have mistargeting of the cystic ﬁbrosis transmem-
brane conductance regulator (CFTR) that results in liver damage
(Feranchak and Sokol, 2001), while those with progressive familial
intrahepatic cholestasis (PFIC) syndromes have mutations in spe-
ciﬁc bile component transporters that result in a lack of protein
or impaired transport to the hepatocyte plasma membrane
(Carlton et al., 2004). Thus, disorders in which proteins aremistargeted lead to biliary defects, although these defects do not
seem to be developmental.
With respect to pn and other mutants and morphants with defects
in pathways affecting late endosomes and lysosomes, defects may
arise from accumulation of cytotoxic proteins and/or abnormal traf-
ﬁcking of proteins important in biliary development. Speciﬁc media-
tors of biliary development such as Jagged/Notch and TGFβ may be
affected, as vesicular acidiﬁcation and intracellular trafﬁcking are im-
portant in the activity for both signaling pathways. Jagged and Notch
family members have clearly been implicated in biliary development
in mammals and zebraﬁsh (Loomes et al., 2007; Lorent et al., 2004;
Ryan et al., 2008; Zong et al., 2009), and TGFβ plays a role in biliary
development through interaction with Hnf6 activity (Clotman et al.,
2005) and possibly an effect on Notch target genes (Blokzijl et al.,
2003). Both Jagged and Notch undergo endocytosis to initiate and ter-
minate signaling between adjacent cells (Nichols et al., 2007), and
proteolytic cleavage of Notch is critical at several steps in activation
(Kadesch, 2004). Acidiﬁcation of TGFβ leads to activation and release
from intracellular vesicles (Gleizes et al., 1997; Roth-Eichhorn et al.,
1998), and the endocytic internalization of the TGFβ receptor is re-
quired for signaling (Le Roy and Wrana, 2005). The requirement for
both Jagged/Notch and TGFβ signaling suggests possible mechanisms
by which abnormal intracellular trafﬁcking could lead to develop-
mental biliary defects. Alternatively, impaired degradation of proteins
in biliary cells could lead to the effects as well.
Mutations in V-H+-ATPase genes would be expected to cause
abnormalities in intravesicular acidiﬁcation. While no liver diseases
speciﬁcally attributed to impaired organelle acidiﬁcation have been
described, disorders of organelles in which establishment of low pH
is critical, such as lysosomes, are important causes of liver disease.
Infants with lysosomal storage diseases such as Niemann-Pick C
and Gaucher disease present with cholestasis, suggesting that ab-
normal intracompartmental pH, as would be generated by V-H+-
ATPase defects, can result in infantile cholestatic disorders. Again,
these disorders do not appear to be developmental in etiology,
but their occurrence during infancy, when intrahepatic bile ducts
continue to be remodeled, suggests that there may be an impact
on developmental processes.
We and others have demonstrated an association between inhibi-
tion of trafﬁcking genes and a phenotype involving skin and eye
hypopigmentations, developmental biliary defects, and defects in or-
ganelles involved in intracellular trafﬁcking in other digestive tis-
sues. While this association suggests an importance of these genes
in the affected processes, the effect may be indirect, and we cannot
exclude the possibility that the observed phenotypes may be the re-
sult of some other effects of inhibition of trafﬁcking genes. One pos-
sible alternative that would be an effect of these proteins on cell
polarity pathways, including planar cell polarity, which we have re-
cently shown plays an important role in biliary morphogenesis (Cui
et al., 2011a).
We have presented mutants affecting biliary development in zeb-
raﬁsh, including another example of a mutant in which an intracellu-
lar trafﬁcking pathway is impaired. Continued analysis of these
mutants and others will likely uncover genes and pathways not pre-
viously appreciated as important in biliary development. These mu-
tants also provide further models of biliary defects, which should
allow greater understanding of such defects in patients.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2012.03.009.
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